I posted ages ago when Maria was being paid 400k (on the same issue, now being paid almost 700k). All a little excessive based on performance IMO. I hope they manage to sell some tests as management have been paying themselves in line with something other than profits. As once the current issue passes the company is back to business as usual. Loss 2014 1.4m 2015 3.3m 2016 3.4m 2017 4.5m 2018 3.7m 2019 5.7m. Complete disregard for shareholders IMO. Good luck with your investment.
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement, page-57
Add AN1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1199234 | 0.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.9¢ | 340000 | 1 |
View Market Depth
| Last trade - 16.12pm 09/07/2024 (20 minute delay) ? |
| AN1 (ASX) Chart |
Day chart unavailable